首页> 中文期刊> 《世界中医药》 >三七降脂粉对高脂血症合并脂肪肝患者降血脂作用的影响研究

三七降脂粉对高脂血症合并脂肪肝患者降血脂作用的影响研究

         

摘要

目的:探讨三七降脂粉对高脂血症合并脂肪肝患者降血脂作用的影响研究.方法:选取武汉市普仁医院收治的高脂血症合并脂肪肝患者79例,采用随机数字表法将患者分为治疗组(40例)与对照组(39例),对照组患者采用辛伐他汀降血脂治疗,治疗组患者在对照组的基础上采用三七降脂粉治疗,比较2组患者临床疗效、血脂水平与超声检查征象的差异.结果:治疗组有效率明显高于对照组(P<0.05).治疗前,2组患者TC、TG、LDL-C、HDL-C水平比较差异无统计学意义(P>0.05),治疗后,全部患者TC、TG、LDL-C水平明显低于治疗前(P<0.05),HDL-C水平明显高于治疗前(P<0.05),治疗组患者TC、TG、LDL-C水平明显低于对照组(P<0.05),HDL-C水平明显高于对照组(P<0.05).治疗组肝脏正常/减小比例,肝脏回声衰减比例明显高于对照组(P<0.05).结论:三七降脂粉对高脂血症合并脂肪肝患者降血脂作用显著,且显著改善肝脏功能,值得临床推广应用.%Objective:To study the effect of Sanqi Jiangzhi Powder on lowing blood liquid of patients with hyperlipidemia and he -patic steatosis.Methods:Seventy-nine cases of hyperlipidemia combined with fatty liver treated in the hospital were selected and divided into observation group (40 cases) and control group (39 cases) by random number table method .Patients in the control group were treated by simvastatin cholesterol-lowering treatment , while patients in the observation group were additionally given Sanqi Jiangzhi Powder .Differences of clinical effect , lipid levels and B ultrasonic examination signs between the two groups were compared .Results:The efficacy rate of the observation group was significantly higher than that of the control group with a statisti -cally significant difference (P<0.05).There was no statistically significant difference in TC , TG, LDL, HDL-C levels of patients of the two groups before the treatment (P>0.05), while TC, TG, LDL-C levels of all patients were significantly lower after treat-ment (P<0.05).HDL-C level was significantly higher (P<0.05) and TC, TG and LDL-C levels of the observation group were significantly lower than those of the control group ( P<0.05) .HDL-C level was significantly higher than that of the control group (P<0.05).The liver normal /reduced proportion and liver echo attenuation proportion of the observation group were significantly higher than those of the control group (P<0.05).Conclusion:Sanqi Jiangzhi Powder has significant effect of lowing blood liquid for patients with hyperlipidemia and fatty liver and significantly improve liver function , which is worthy of clinical popularization and application .

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号